uspto.gov
Skip over navigation

Biotechnology/Chemical/Pharmaceutical Customer Partnership

Biotechnology and Chemical Pharmaceutical Customer Partnership Meeting
Wednesday September 13, 2006

United States Patent and Trademark Office
Alexandria, Virginia
Madison Auditorium South
600 Dulany Street, Alexandria, VA

The next meeting of the U.S. Patent and Trademark Office Biotechnology and Chemical Pharmaceutical Customer Partnership is scheduled for Wednesday, September 13, 2006 from 9:00 am to 4:30 PM at Auditorium South in Madison Building, 600 Dulany Street, Alexandria, Virginia.

This meeting is also available on-line. Participation is limited to the first 200 individual registrants; so, if you are interested in attending this September meeting, please click on the link below to register:

The most recent quarterly meeting for the Biotechnology and Chemical Pharmaceutical Customer Partnership was held on June 13, 2006 at the U.S. Patent and Trademark Office. The Biotechnology and Chemical Pharmaceutical Customer Partnership is designed and developed to be a forum to share ideas, experiences, and insights between individual users and the USPTO. The USPTO does not intend to use these customer partnership groups to arrive at any consensus. Invitations to participate will indicate that individual opinions are sought, rather than a group consensus and that the meetings are intended to be informal in nature and have varying participants. These customer partnership groups are formed with full recognition of the USPTO's responsibility under the Federal Advisory Committee Act (FACA), and that these customer partnership groups are not established as FACA compliant committees.

We value our customers in obtaining feedback from individual participants is important in our efforts to continuously improve the quality of our products and services. Your willing participation is helpful in providing us with insights and experiences in this informal process to assist us.

For information of future meetings and presentations, please go to http://www.cabic.com/bcp/.

Please contact Cecilia Tsang at 571-272-0562, or by fax at 571-273-0562, or email Cecilia.Tsang@uspto.gov to decline or confirm your attendance by September 7, 2006.

Place: In-person: Auditorium South in Madison Building, 600 Dulany Street, Alexandria, Virginia

For information of future meetings and presentations, please go to http://www.cabic.com/bcp/

Please contact Cecilia Tsang at 571-272-0562, or by fax at 571-273-0562, or email Cecilia.Tsang@uspto.gov to decline or confirm your attendance by June 7, 2006.

Time Morning Session Presenter
9:00-9:15
Greetings and Overview
John LeGuyader, Bruce Kisliuk, George C. Elliott, Directors, Technology Center 1600
9:15-10:45
USPTO Restriction Training Materials and Chapter 800 Revisions
Kathleen Kerr, SPE, 1656; Mike Hartley, SPE, 1618;
Peter Paras, SPE, 1635/1639; Deborah Reynolds, tQAS
10:45-11:00
Break
11:00-11:20
Restriction Petitions and Helpful Hints
Julie Burke, Special Program Examiner, TC1600
11:20-12:00
New Accelerated Examination Program
Andrew Faile, Director Technology Center 2600
12:00-1:15
Lunch
 
Time Afternoon Session Presenter
1:15-2:00
Bioinformatics and 35 U.S.C. 101
Andrew Wang, Supervisory Patent Examiner, Art Unit 1631
2:00-2:45
Types of Vaccines and Patentability Considerations
Christina Chan, Supervisory Patent Examiner, Art Unit 1644
2:45-3:00
Break
 
3:00-3:45
35 U.S.C. 112, 6th paragraph as applies to Biotech and Chemical Practice
Ram Shukla, Supervisory Patent Examiner, Art Unit 1632 and 1634
3:45-4:00
Closing Remarks/Discussion
John LeGuyader, Bruce Kisliuk, George C. Elliott, Directors, TC 1600
United States Patent and Trademark Office
This page is owned by Technology Center 1600.
Last Modified: 7/4/2009 6:08:28 PM